What’s new with neuroprotective agents in stroke?
Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Bankhead, Charles [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
1998 |
|---|
| Schlagwörter: |
|---|
| Anmerkung: |
© Adis International Ltd 1998 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 1127(1998), 1 vom: März, Seite 9-10 |
|---|---|
| Übergeordnetes Werk: |
volume:1127 ; year:1998 ; number:1 ; month:03 ; pages:9-10 |
| Links: |
|---|
| DOI / URN: |
10.2165/00128413-199811270-00016 |
|---|
| Katalog-ID: |
SPR036247278 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | SPR036247278 | ||
| 003 | DE-627 | ||
| 005 | 20230519135923.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201007s1998 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2165/00128413-199811270-00016 |2 doi | |
| 035 | |a (DE-627)SPR036247278 | ||
| 035 | |a (SPR)00128413-199811270-00016-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bankhead, Charles |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a What’s new with neuroprotective agents in stroke? |
| 264 | 1 | |c 1998 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a © Adis International Ltd 1998 | ||
| 520 | |a Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. | ||
| 650 | 4 | |a Placebo Recipient |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Acute Stroke |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Acute Ischaemic Stroke |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Barthel Index |7 (dpeaa)DE-He213 | |
| 650 | 4 | |a Severe Stroke |7 (dpeaa)DE-He213 | |
| 773 | 0 | 8 | |i Enthalten in |t Inpharma weekly |d Auckland : ADIS internat., 1975 |g 1127(1998), 1 vom: März, Seite 9-10 |w (DE-627)373977859 |w (DE-600)2127607-9 |x 2230-6056 |7 nnns |
| 773 | 1 | 8 | |g volume:1127 |g year:1998 |g number:1 |g month:03 |g pages:9-10 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.2165/00128413-199811270-00016 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_SPRINGER | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 951 | |a AR | ||
| 952 | |d 1127 |j 1998 |e 1 |c 03 |h 9-10 | ||
| author_variant |
c b cb |
|---|---|
| matchkey_str |
article:22306056:1998----::htnwiherpoetvae |
| hierarchy_sort_str |
1998 |
| publishDate |
1998 |
| allfields |
10.2165/00128413-199811270-00016 doi (DE-627)SPR036247278 (SPR)00128413-199811270-00016-e DE-627 ger DE-627 rakwb eng Bankhead, Charles verfasserin aut What’s new with neuroprotective agents in stroke? 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1998 Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. Placebo Recipient (dpeaa)DE-He213 Acute Stroke (dpeaa)DE-He213 Acute Ischaemic Stroke (dpeaa)DE-He213 Barthel Index (dpeaa)DE-He213 Severe Stroke (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1127(1998), 1 vom: März, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1127 year:1998 number:1 month:03 pages:9-10 https://dx.doi.org/10.2165/00128413-199811270-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1127 1998 1 03 9-10 |
| spelling |
10.2165/00128413-199811270-00016 doi (DE-627)SPR036247278 (SPR)00128413-199811270-00016-e DE-627 ger DE-627 rakwb eng Bankhead, Charles verfasserin aut What’s new with neuroprotective agents in stroke? 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1998 Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. Placebo Recipient (dpeaa)DE-He213 Acute Stroke (dpeaa)DE-He213 Acute Ischaemic Stroke (dpeaa)DE-He213 Barthel Index (dpeaa)DE-He213 Severe Stroke (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1127(1998), 1 vom: März, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1127 year:1998 number:1 month:03 pages:9-10 https://dx.doi.org/10.2165/00128413-199811270-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1127 1998 1 03 9-10 |
| allfields_unstemmed |
10.2165/00128413-199811270-00016 doi (DE-627)SPR036247278 (SPR)00128413-199811270-00016-e DE-627 ger DE-627 rakwb eng Bankhead, Charles verfasserin aut What’s new with neuroprotective agents in stroke? 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1998 Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. Placebo Recipient (dpeaa)DE-He213 Acute Stroke (dpeaa)DE-He213 Acute Ischaemic Stroke (dpeaa)DE-He213 Barthel Index (dpeaa)DE-He213 Severe Stroke (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1127(1998), 1 vom: März, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1127 year:1998 number:1 month:03 pages:9-10 https://dx.doi.org/10.2165/00128413-199811270-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1127 1998 1 03 9-10 |
| allfieldsGer |
10.2165/00128413-199811270-00016 doi (DE-627)SPR036247278 (SPR)00128413-199811270-00016-e DE-627 ger DE-627 rakwb eng Bankhead, Charles verfasserin aut What’s new with neuroprotective agents in stroke? 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1998 Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. Placebo Recipient (dpeaa)DE-He213 Acute Stroke (dpeaa)DE-He213 Acute Ischaemic Stroke (dpeaa)DE-He213 Barthel Index (dpeaa)DE-He213 Severe Stroke (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1127(1998), 1 vom: März, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1127 year:1998 number:1 month:03 pages:9-10 https://dx.doi.org/10.2165/00128413-199811270-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1127 1998 1 03 9-10 |
| allfieldsSound |
10.2165/00128413-199811270-00016 doi (DE-627)SPR036247278 (SPR)00128413-199811270-00016-e DE-627 ger DE-627 rakwb eng Bankhead, Charles verfasserin aut What’s new with neuroprotective agents in stroke? 1998 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1998 Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. Placebo Recipient (dpeaa)DE-He213 Acute Stroke (dpeaa)DE-He213 Acute Ischaemic Stroke (dpeaa)DE-He213 Barthel Index (dpeaa)DE-He213 Severe Stroke (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 1127(1998), 1 vom: März, Seite 9-10 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:1127 year:1998 number:1 month:03 pages:9-10 https://dx.doi.org/10.2165/00128413-199811270-00016 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 1127 1998 1 03 9-10 |
| language |
English |
| source |
Enthalten in Inpharma weekly 1127(1998), 1 vom: März, Seite 9-10 volume:1127 year:1998 number:1 month:03 pages:9-10 |
| sourceStr |
Enthalten in Inpharma weekly 1127(1998), 1 vom: März, Seite 9-10 volume:1127 year:1998 number:1 month:03 pages:9-10 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
Placebo Recipient Acute Stroke Acute Ischaemic Stroke Barthel Index Severe Stroke |
| isfreeaccess_bool |
false |
| container_title |
Inpharma weekly |
| authorswithroles_txt_mv |
Bankhead, Charles @@aut@@ |
| publishDateDaySort_date |
1998-03-01T00:00:00Z |
| hierarchy_top_id |
373977859 |
| id |
SPR036247278 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036247278</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519135923.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1998 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199811270-00016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036247278</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199811270-00016-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bankhead, Charles</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">What’s new with neuroprotective agents in stroke?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1998</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1998</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Placebo Recipient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Stroke</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Ischaemic Stroke</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Barthel Index</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Severe Stroke</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1127(1998), 1 vom: März, Seite 9-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1127</subfield><subfield code="g">year:1998</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:9-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199811270-00016</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1127</subfield><subfield code="j">1998</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">9-10</subfield></datafield></record></collection>
|
| author |
Bankhead, Charles |
| spellingShingle |
Bankhead, Charles misc Placebo Recipient misc Acute Stroke misc Acute Ischaemic Stroke misc Barthel Index misc Severe Stroke What’s new with neuroprotective agents in stroke? |
| authorStr |
Bankhead, Charles |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)373977859 |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
springer |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
2230-6056 |
| topic_title |
What’s new with neuroprotective agents in stroke? Placebo Recipient (dpeaa)DE-He213 Acute Stroke (dpeaa)DE-He213 Acute Ischaemic Stroke (dpeaa)DE-He213 Barthel Index (dpeaa)DE-He213 Severe Stroke (dpeaa)DE-He213 |
| topic |
misc Placebo Recipient misc Acute Stroke misc Acute Ischaemic Stroke misc Barthel Index misc Severe Stroke |
| topic_unstemmed |
misc Placebo Recipient misc Acute Stroke misc Acute Ischaemic Stroke misc Barthel Index misc Severe Stroke |
| topic_browse |
misc Placebo Recipient misc Acute Stroke misc Acute Ischaemic Stroke misc Barthel Index misc Severe Stroke |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
cr |
| hierarchy_parent_title |
Inpharma weekly |
| hierarchy_parent_id |
373977859 |
| hierarchy_top_title |
Inpharma weekly |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)373977859 (DE-600)2127607-9 |
| title |
What’s new with neuroprotective agents in stroke? |
| ctrlnum |
(DE-627)SPR036247278 (SPR)00128413-199811270-00016-e |
| title_full |
What’s new with neuroprotective agents in stroke? |
| author_sort |
Bankhead, Charles |
| journal |
Inpharma weekly |
| journalStr |
Inpharma weekly |
| lang_code |
eng |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
1998 |
| contenttype_str_mv |
txt |
| container_start_page |
9 |
| author_browse |
Bankhead, Charles |
| container_volume |
1127 |
| format_se |
Elektronische Aufsätze |
| author-letter |
Bankhead, Charles |
| doi_str_mv |
10.2165/00128413-199811270-00016 |
| title_sort |
what’s new with neuroprotective agents in stroke? |
| title_auth |
What’s new with neuroprotective agents in stroke? |
| abstract |
Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. © Adis International Ltd 1998 |
| abstractGer |
Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. © Adis International Ltd 1998 |
| abstract_unstemmed |
Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference. © Adis International Ltd 1998 |
| collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 |
| container_issue |
1 |
| title_short |
What’s new with neuroprotective agents in stroke? |
| url |
https://dx.doi.org/10.2165/00128413-199811270-00016 |
| remote_bool |
true |
| ppnlink |
373977859 |
| mediatype_str_mv |
c |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| doi_str |
10.2165/00128413-199811270-00016 |
| up_date |
2024-07-03T16:51:20.648Z |
| _version_ |
1803577438397005824 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR036247278</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519135923.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1998 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.2165/00128413-199811270-00016</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR036247278</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)00128413-199811270-00016-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Bankhead, Charles</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">What’s new with neuroprotective agents in stroke?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1998</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1998</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract Neuroprotective agents demonstrated only modest benefits in several clinical trials reported at the American Heart Association’s 23rd Annual Joint Conference on Stroke and Cerebral Circulation [Orlando, US; February 1998]. No overall benefit emerged from studies of citicoline, clomethiazole or lubeluzole. However, subgroup analyses identified certain patient populations that did derive significant benefit from treatment and that may represent target treatment groups for future trials, delegates were told at the conference.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Placebo Recipient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Stroke</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Acute Ischaemic Stroke</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Barthel Index</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Severe Stroke</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">1127(1998), 1 vom: März, Seite 9-10</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:1127</subfield><subfield code="g">year:1998</subfield><subfield code="g">number:1</subfield><subfield code="g">month:03</subfield><subfield code="g">pages:9-10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.2165/00128413-199811270-00016</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">1127</subfield><subfield code="j">1998</subfield><subfield code="e">1</subfield><subfield code="c">03</subfield><subfield code="h">9-10</subfield></datafield></record></collection>
|
| score |
7.399294 |